you are here: Home News Daiichi Sankyo

Daiichi Sankyo

IHH Healthcare's unit seeks up to $1.25 billion from Japan's Daiichi over Fortis deal
IHH hopes to soon float open offer for Fortis Healthcare, says its MD & CEO
EX-promoters of Fortis Healthcare failed to purge themselves of contempt, says SC
Fortis Healthcare shares drop 20% as Supreme Court orders status quo on IHH deal
SC likely to pronounce verdict on IHH open offer for Fortis tomorrow
Ranbaxy-Daiichi case: SC asks lenders to place loan records of Malvinder, Shivinder
AstraZeneca bets up to $6 billion on new Daiichi cancer drug
SC asks ex-Ranbaxy promoters to apprise it of complying with Rs 3,500 cr arbitral award
IHH puts Fortis open offer on hold, says seeking legal advice on SC's order
Daiichi Sankyo says Singh brothers diverted Rs 2,900 crore through downstream companies
Daiichi Sankyo moves NCLT to stay insolvency plea against RHC Holding
Daiichi arbitration case: Delhi High Court orders attachment of Singh brothers' declared assets
Daiichi moves Delhi HC again to ban Fortis from selling stakes
Daiichi case: HC asks Singh bros to declare value of total stake
Fortis stake sale: Delhi HC to hear Daiichi plea on Jan 23
Daiichi to shut down Indian R&D centre; 170 employees impacted
Lupin shares rebound on USFDA nod for anti-hypertensive drug
Sun Pharma, Daiichi terminate transaction pacts
Govt to commission study on impact of FDI in pharma
HSBC downgrades Indian equities to underweight
Rupee declines second straight week against USD
Shanghvi did not buy Daiichi Sankyo's shares: Sun Pharma
Sun Pharma gains 3%, JP Morgan overweight post massive fall
Sun Pharma plunges 11% as Daiichi Sankyo sells 8.9% stake
Daiichi Sankyo to offload stake in Sun Pharma

English

Markets

News

Personal Finance

Mutual Funds

Commodities

Media

Invest Now

Specials

Daiichi Sankyo

IHH Healthcare's unit seeks up to $1.25 billion from Japan's Daiichi over Fortis deal

IHH hopes to soon float open offer for Fortis Healthcare, says its MD & CEO

EX-promoters of Fortis Healthcare failed to purge themselves of contempt, says SC

Fortis Healthcare shares drop 20% as Supreme Court orders status quo on IHH deal

SC likely to pronounce verdict on IHH open offer for Fortis tomorrow

Ranbaxy-Daiichi case: SC asks lenders to place loan records of Malvinder, Shivinder

AstraZeneca bets up to $6 billion on new Daiichi cancer drug

SC asks ex-Ranbaxy promoters to apprise it of complying with Rs 3,500 cr arbitral award

IHH puts Fortis open offer on hold, says seeking legal advice on SC's order

Daiichi Sankyo says Singh brothers diverted Rs 2,900 crore through downstream companies

Daiichi Sankyo moves NCLT to stay insolvency plea against RHC Holding

Daiichi arbitration case: Delhi High Court orders attachment of Singh brothers' declared assets

Daiichi moves Delhi HC again to ban Fortis from selling stakes

Daiichi case: HC asks Singh bros to declare value of total stake

Fortis stake sale: Delhi HC to hear Daiichi plea on Jan 23

Daiichi to shut down Indian R&D centre; 170 employees impacted

Lupin shares rebound on USFDA nod for anti-hypertensive drug

Sun Pharma, Daiichi terminate transaction pacts

Govt to commission study on impact of FDI in pharma

HSBC downgrades Indian equities to underweight

Rupee declines second straight week against USD

Shanghvi did not buy Daiichi Sankyo's shares: Sun Pharma

Sun Pharma gains 3%, JP Morgan overweight post massive fall

Sun Pharma plunges 11% as Daiichi Sankyo sells 8.9% stake

Daiichi Sankyo to offload stake in Sun Pharma